COOPER COMPANIES, INC.
COOAPI behind this page
COO Q3 2025 request
Playground key active
/api/financials?ticker=COO&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 1,060.3 | 1,002.8 | +5.7% |
Show Product Lines breakouts |
|||
| Fertility · CooperSurgical | 137.1 | 129.3 | +6.0% |
| Office and surgical · CooperSurgical | 204.8 | 197.9 | +3.5% |
| Sphere, other · CooperVision | 359.6 | 349.2 | +3.0% |
| Toric and multifocal · CooperVision | 358.8 | 326.4 | +9.9% |
Show Business Segments breakouts |
|||
| CooperSurgical · Operating Segments | 341.9 | 327.2 | +4.5% |
| CooperVision · Operating Segments | 718.4 | 675.6 | +6.3% |
Show Geography breakouts |
|||
| Europe | 343.1 | 297 | +15.5% |
| Rest of world | 201 | 194.6 | +3.3% |
| US | 516.2 | 511.2 | +1.0% |
| Cost of Revenue | 368.3 | 339.8 | +8.4% |
| Gross Profit | 692 | 663 | +4.4% |
| Selling, General & Administrative | 421.7 | 381.1 | +10.7% |
| Research & Development | 44.6 | 39 | +14.4% |
| Amortization Of Intangible Assets | 50 | 50.4 | -0.8% |
| Operating Income | 175.7 | 192.5 | -8.7% |
Show Business Segments breakouts |
|||
| CooperSurgical · Operating Segments | -4.2 | 41.3 | -110.2% |
| CooperVision · Operating Segments | 202.6 | 172.7 | +17.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -22.7 | -21.5 | -5.6% |
| Interest Expense | 25.4 | 28.5 | -10.9% |
| Other Non-Operating Income (Expense) | -1.6 | 0.3 | -633.3% |
| Income Before Taxes | 151.9 | 163.7 | -7.2% |
| Income Tax Expense (Benefit) | 53.6 | 59 | -9.2% |
| Net Income | 98.3 | 104.7 | -6.1% |
Show Equity Components breakouts |
|||
| Retained Earnings | 98.3 | 104.7 | -6.1% |
| EPS (Basic) | 0.49 | 0.53 | -7.5% |
| EPS (Diluted) | 0.49 | 0.52 | -5.8% |
| Wtd Avg Shares (Basic) | 199.3 | 199.1 | +0.1% |
| Wtd Avg Shares (Diluted) | 200 | 200.6 | -0.3% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | 3.9 | -27.2 | +114.3% |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -3.7 | 24.7 | -115.0% |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | 98.5 | 102.2 | -3.6% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | 9.9 | -16.5 | +160.0% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 124.9 | 109.7 | +13.9% |
| Accounts Receivable | 792.3 | 739 | +7.2% |
| Inventory | 881 | — | — |
| Prepaid Expenses & Other Current Assets | 339.6 | 298.7 | +13.7% |
| Total Current Assets | 2,137.8 | 1,926.7 | +11.0% |
| Non-Current Assets | |||
| Goodwill | 3,861.8 | — | — |
| Deferred Tax Assets | 2,099.2 | 2,248.3 | -6.6% |
| Other Non-Current Assets | 653.3 | 621.4 | +5.1% |
| Total Assets | 12,376.7 | 12,108 | +2.2% |
Show Business Segments breakouts |
|||
| CooperSurgical · Operating Segments | 4,671 | 4,716.8 | -1.0% |
| CooperVision · Operating Segments | 7,511.7 | 7,172 | +4.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 194 | 219.2 | -11.5% |
| Intangible Assets | 1,634.8 | — | — |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 1,988.7 | — | — |
| Intangible Assets Net Excluding Goodwill | 1,635.9 | — | — |
| Current Liabilities | |||
| Debt Current | 46.9 | — | — |
| Accounts Payable | 255.9 | 222 | +15.3% |
| Employee Related Liabilities Current | 181.1 | 156.5 | +15.7% |
| Deferred Revenue (Current) | 126.6 | 126.4 | +0.2% |
| Other Liabilities Current | 399.6 | 423.8 | -5.7% |
| Total Current Liabilities | 1,010.1 | 969.5 | +4.2% |
| Non-Current Liabilities | |||
| Deferred Tax Liabilities | 101.8 | 94.9 | +7.3% |
| Accrued Income Taxes Noncurrent | 17.8 | 59 | -69.8% |
| Contract With Customer Liability Noncurrent | 199.4 | 190.8 | +4.5% |
| Other Non-Current Liabilities | 263.2 | 277 | -5.0% |
| Total Liabilities | 4,023.7 | 4,182.8 | -3.8% |
| Long-Term Debt | 2,429.5 | — | — |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 2,431.4 | — | — |
| Stockholders' Equity | |||
| Common Stock | 21.8 | 21.7 | +0.5% |
| Additional Paid-In Capital | 1,960.4 | 1,884.7 | +4.0% |
| Accumulated Other Comprehensive Income | -392.1 | -425.1 | +7.8% |
| Retained Earnings | 7,558.7 | 7,150.9 | +5.7% |
| Treasury Stock Common Value | -796 | -707.2 | -12.6% |
| Total Stockholders' Equity | 8,352.8 | 7,925 | +5.4% |
| Minority Interest | 0.2 | 0.2 | 0.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 8,353 | 7,925.2 | +5.4% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -4.9 | -3.2 | -53.1% |
| Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent | 35.8 | 70.7 | -49.4% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 27.2 | 53.6 | -49.3% |
| Accumulated Other Comprehensive Income | -392.1 | -425.1 | +7.8% |
| Accumulated Translation Adjustment | -414.4 | -475.5 | +12.8% |
| Additional Paid In Capital | 1,960.4 | 1,884.7 | +4.0% |
| Common Shares | 20 | 19.9 | +0.5% |
| Noncontrolling Interest | 0.2 | 0.2 | 0.0% |
| Retained Earnings | 7,558.7 | 7,150.9 | +5.7% |
| Treasury Stock | 1.8 | 1.8 | 0.0% |
| Treasury Stock Common | -796 | -707.2 | -12.6% |
| Total Liabilities & Equity | 12,376.7 | 12,108 | +2.2% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 279 | 284.1 | -1.8% |
| Increase Decrease In Operating Capital | -259.7 | -302.5 | +14.1% |
| Deferred Income Taxes | 122.2 | 96.9 | +26.1% |
| Other Non-Cash Items | 116.4 | 87.9 | +32.4% |
| Net Cash from Operations | 548.2 | 441.2 | +24.3% |
| Investing Activities | |||
| Capital Expenditures | -264.4 | -281.2 | +6.0% |
| Payments To Acquire Businesses And Assets Net Of Cash Acquired And Other | -9.7 | -241.8 | +96.0% |
| Net Cash from Investing | -274.1 | -523 | +47.6% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 2,174.9 | 2,807.8 | -22.5% |
| Repayments Of Long Term Debt | -2,294.7 | -2,749.2 | +16.5% |
| Payments To Acquire Business Gross Installments | -47.1 | — | — |
| Proceeds From Repayments Of Short Term Debt | 11.9 | -3.4 | +450.0% |
| Proceeds From Payments Of Share Based Arrangement | -19.7 | 6.5 | -403.1% |
| Share Repurchases | -93.3 | — | — |
| Proceeds From Stock Plans | 6.5 | 5.9 | +10.2% |
| Net Cash from Financing | -261.5 | 67.6 | -486.8% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4.6 | 3.1 | +48.4% |
| Net Change in Cash | 17.2 | -11.1 | +255.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 124.9 | 109.8 | +13.8% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.